These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12841936)

  • 21. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.
    Zomorodi K; Donner A; Somma J; Barr J; Sladen R; Ramsay J; Geller E; Shafer SL
    Anesthesiology; 1998 Dec; 89(6):1418-29. PubMed ID: 9856717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study for validation of Bayesian prediction approach to adjust individual lidocaine dosage.
    Uematsu T; Hirayama H; Umemura K; Kosuge K; Nakashima M
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):33-7. PubMed ID: 8199750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.
    Henry RJ; Ruano N; Casto D; Wolf RH
    Pediatr Dent; 1998; 20(5):321-6. PubMed ID: 9803431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study.
    Ghori KA; Harmon DC; Elashaal A; Butler M; Walsh F; O'Sullivan MG; Shorten GD
    Crit Care Resusc; 2007 Jun; 9(2):166-71. PubMed ID: 17536986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single plasma concentrations of 1'-hydroxymidazolam or the ratio of 1'-hydroxymidazolam:midazolam do not predict midazolam clearance in healthy subjects.
    Rogers JF; Nafziger AN; Kashuba AD; Streetman DS; Rocci ML; Choo EF; Wilkinson GR; Bertino JS
    J Clin Pharmacol; 2002 Oct; 42(10):1079-82. PubMed ID: 12362920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effect of protocol-directed sedation with propofol vs. midazolam by nurses in intensive care: efficacy, haemodynamic stability and patient satisfaction.
    Huey-Ling L; Chun-Che S; Jen-Jen T; Shau-Ting L; Hsing-I C
    J Clin Nurs; 2008 Jun; 17(11):1510-7. PubMed ID: 18482144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam--a pilot study.
    Sackey PV; Martling CR; Carlswärd C; Sundin O; Radell PJ
    Crit Care Med; 2008 Mar; 36(3):801-6. PubMed ID: 18431266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
    Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
    Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis.
    de Miranda Silva C; Fernandes BJ; Donadi EA; Silva LM; Coelho EB; Dantas M; Marques MP; Lanchote VL
    J Clin Pharmacol; 2009 Aug; 49(8):965-72. PubMed ID: 19546252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis.
    Dasta JF; Jacobi J; Sesti AM; McLaughlin TP
    Pharmacotherapy; 2006 Jun; 26(6):798-805. PubMed ID: 16716133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of dexmedetomidine in the pediatric intensive care unit.
    Buck ML; Willson DF
    Pharmacotherapy; 2008 Jan; 28(1):51-7. PubMed ID: 18154474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of radioreceptor assay and gas liquid chromatography in pharmacokinetic studies on midazolam.
    Aaltonen L; Himberg JJ; Kanto J; Vuori A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):247-52. PubMed ID: 3159689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.
    Barnes BJ; Gerst C; Smith JR; Terrell AR; Mullins ME
    Pharmacotherapy; 2006 Jan; 26(1):23-33. PubMed ID: 16422667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.
    Ludden TM; Beal SL; Peck CC; Godley PJ
    Clin Pharm; 1986 Jul; 5(7):580-5. PubMed ID: 3755661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Midazolam--how safe is it in sedation of newborn?].
    Gulczyńska E
    Pol Merkur Lekarski; 2005 Dec; 19(114):816-8. PubMed ID: 16521431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.